These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34334170)

  • 1. Medication-Related Osteonecrosis of the Jaw (MRONJ).
    Ferneini EM
    J Oral Maxillofac Surg; 2021 Aug; 79(8):1801-1802. PubMed ID: 34334170
    [No Abstract]   [Full Text] [Related]  

  • 2. Pembrolizumab related osteonecrosis of the jaw.
    Patel V; Carey B
    Br J Oral Maxillofac Surg; 2023 Dec; 61(10):704-706. PubMed ID: 37957097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
    Somay E
    Osteoporos Int; 2023 Oct; 34(10):1811-1812. PubMed ID: 37418153
    [No Abstract]   [Full Text] [Related]  

  • 4. "Spontaneous" medication-related osteonecrosis of the jaw; two case reports and a systematic review.
    Khominsky A; Lim M
    Aust Dent J; 2018 Dec; 63(4):441-454. PubMed ID: 30144095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.
    Ruggiero SL
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):479-87. PubMed ID: 26293329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to: Prognosis of metastatic bone cancer and myeloma patients and long‑term risk of medication‑related osteonecrosis of the jaw (MRONJ): some critical points.
    Hata H; Imamachi K; Ueda M; Matsuzaka M; Hiraga H; Osanai T; Harabayashi T; Fujimoto K; Oizumi S; Takahashi M; Yoshikawa K; Sato J; Yamazaki Y; Kitagawa Y
    Support Care Cancer; 2022 Dec; 30(12):9693-9695. PubMed ID: 36318340
    [No Abstract]   [Full Text] [Related]  

  • 7. Medication-Related Osteonecrosis of the Jaw.
    Chen YF; Chang HP
    N Engl J Med; 2023 May; 388(21):e69. PubMed ID: 37212416
    [No Abstract]   [Full Text] [Related]  

  • 8. [Osteonecrosis of the jaw].
    Drozdzowska B
    Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
    Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
    Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteonecrosis of the Jaw.
    Hamdy RC
    J Clin Densitom; 2017; 20(1):1-2. PubMed ID: 28259260
    [No Abstract]   [Full Text] [Related]  

  • 11. Emerging therapies with potential risks of medicine-related osteonecrosis of the jaw: a review of the literature.
    Kanwar N; Bakr MM; Meer M; Siddiqi A
    Br Dent J; 2020 Jun; 228(11):886-892. PubMed ID: 32541753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiresorptive drug-related osteonecrosis of the jaw.
    Uyanne J; Calhoun CC; Le AD
    Dent Clin North Am; 2014 Apr; 58(2):369-84. PubMed ID: 24655528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
    Dodson TB
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: AAOMS Position Paper on Medication-Related Osteonecrosis of the Jaw-2022 Update.
    Campisi G; Mauceri R; Bedogni A; Fusco V
    J Oral Maxillofac Surg; 2022 Nov; 80(11):1723-1724. PubMed ID: 36332990
    [No Abstract]   [Full Text] [Related]  

  • 16. Jaw osteonecrosis related to cabozantinib.
    Sánchez López JD; Rodríguez Ruiz JA; Miguel PPT
    Med Clin (Barc); 2021 Jun; 156(12):627-628. PubMed ID: 32883509
    [No Abstract]   [Full Text] [Related]  

  • 17. Incongruities in the AAOMS position paper: medication-related osteonecrosis of the jaw--2014 update.
    Chang JI; Hazboun RC; Chang TI
    J Oral Maxillofac Surg; 2014 Dec; 72(12):2381. PubMed ID: 25315315
    [No Abstract]   [Full Text] [Related]  

  • 18. Medication-Related Osteonecrosis of the Jaw Associated in a Patient Treated With Etanercept.
    Nisi M; Izzetti R; Graziani F
    J Craniofac Surg; 2022 Oct; 33(7):e694-e696. PubMed ID: 35184115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.
    Schoenhof R; Munz A; Yuan A; ElAyouti A; Boesmueller H; Blumenstock G; Reinert S; Hoefert S
    J Craniomaxillofac Surg; 2021 Jun; 49(6):508-517. PubMed ID: 33707134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
    Otto S; Pautke C; Van den Wyngaert T; Niepel D; Schiødt M
    Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.